BAL Lazio

HTA

HTA – Bibliografia 1999-1977

Pubblicato lunedì 5 Maggio 2014

I volumi e gli articoli citati sono in ordine cronologico, in modo da mettere in evidenza quelli più recenti, in cima all’elenco.

Battista RN, Hodge MJ. The evolving paradigm of health technology assessment: reflections for the millennium. CMAJ 1999; 160: 1464-7.

Jonsson E, Banta D. Management of health technologies: an international view. BMJ 1999; 319: 1293.

Rosen R, Gabbey J. Linking health technology assessment to practice. BMJ 1999; 319: 1-3.

Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998; 317: 465-8.

Goodman CS. Technology assessment: A tool for technology management and improved patient outcomes. USA: The Lewin Group, 1998.

Heitman E. Ethical issues in technology assessment. Conceptual categories and procedural considerations. Int J Technol Assess Health Care 1998; 14 (3): 544-66.

Sheldon TA, Guyatt GH, Haines A. Getting research findings in to practice – When to act on evidence. BMJ 1998; 317: 149-52.

Chancellor J, Coyle D, Drummond MF. Constructing health state preference values from descriptive quality of life data: mission impossible? Qual Life Res 1997; 6 (2): 159-68.

Favaretti C, Liberati A, De Pieri P, et al. Dalla medicina all’assistenza sanitaria basata su prove di efficacia: la sfida dell’aziendalizzazione del servizio sanitario nazionale. In: Liberati A, ed. La medicina delle prove di efficacia. Roma: Il Pensiero Scientifico Editore, 1997; 137-61.

Jacob R, Mc Gregor M. Assessing the impact of health technology assessment. Int J Technol Assess Health Care 1997; 13: 68-80.

Birch S, Gafni A. Cost effectiveness and cost utility analysis: methods for the non – economic evaluation of health care programmers and how we can do better. In: Geilser E, Heller O, eds. Managing technology in health care. Norwell, MA: Klewer Academic Publishers, 1996; 51-68.

Epstein RE, Sherwood LM. From outcomes research to disease management: A guide for the perplexed. Ann Intern Med 1996; 124: 832-7.

Raiseman. Management technologies for managing the health care sector technologies. In: Geisler E, Heller O, eds. Managing technology in health care. Boston: Kluwer Academic Publisher, 1996.

Sculpher MJ, Drummond MF, Buxton MJ. The iterative use of economic evaluation as part of the process of health assessment. J Health Serv Res Policy 1996; 1 (4).

Van Roijen L, Essink-Bot ML, Koopmanschap MA, et al. Labor and health status in economic evaluation of health care. Int J Technol Assess Health Care 1996; 12 (3): 405-15.

Battista RN, Vineis P, Hodge MJ. Medicine, practice and guidelines: The uneasy juncture of science and art. J Clin Epidemiol 1995; 48: 875-80.

ten Have H. Medical Technology assessment and ethics. Ambivalent relations. Hastings Cent Rep 1995; 25 (5): 13-9.

Battista RN. Scienze della salute, decisioni politiche e valutazione delle tecnologie sanitarie: sta espandendosi il ruolo degli epidemiologi? Epid Rev 1994 (18): 15-21.

Briggs AH, Schulpher MJ, Buxton MJ. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95-104.

Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life. Ann Intern Med 1993; 118: 622-9.

Johannesson M, Jönsson B. Economic evaluation in health care: is there a role for cost-benefits? Health Policy 1991; 17: 1-23.

Battista RN, Contandriopoulos AP, Champagne F. An integrative framework for health-related research. J Clin Epidemiol 1989; 42 (12): 1155-60.

Deber RB. Metodologie di valutazione della tecnologia e il loro impatto sul “Decision Making”. Proceedings of the Symposium on Health Care Technology Assessment. Quebec City, May 25-26, 1989.

Donabedian A. The assessment of technology and quality: a comparative study of certainties and ambiguities. Int J Tech Assess Health Care 1988; 4: 487-96.

Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5: 1-30.

Jonas H. Technik, medizin und ethik. Zur praxis des prinzips verantwortung. Frankfurt am Main: Insel verlag; 1985 (trad. it. Tecnica, medicina ed etica. Prassi del principio responsabilità. Torino: Giulio Einaudi Editore, 1997).

Drummond MF, Stoddart GL. Economic analysis and clinical trial. Control Clin Trials 1984; 5: 115-28.

Stoddart GL. Economic evaluation methods of health policy. Eval Health Prof 1982; 5 (4): 309-30.

Drummond MF. Welfare economics and cost benefit analysis in health care. Scott Polit Econ 1981; 28: 125-45.

Weinstein MC. Economic assessments of medical practices and technologies. Med Decis Making 1981; 1 (4): 309-30.

Williams AH. Welfare economics and health status measurement. In: van der Gaag J, Pearlman M, ed. Health, economics and health economics. Amsterdam: North Holland, 1981; 271-81.

Mehrez A, Gafni A. Quality adjusted life years, utility theory and health years equivalents. Med Decis Making 1989; 9: 142-9.Sackett DL. Evaluation of health services. In: Last JM. Health and preventive medicine. New York: Appleton – Century Crofts, 1980; 1800-23.

Weinstein MC, Statson WB. Foundations of cost effectiveness analysis for health and medical practices. N Eng J Med 1977; 296: 716-21.

Archiviato in ,

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Accedi agli articoli

Ouldali N et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA. February 1, 2021. Epub ahead of print. doi:10.1001/jama.2021.0694

Freedman RA et al. Individualizing surveillance mammography for older patients after treatment for early-stage breast cancer: multidisciplinary expert panel and International Society of Geriatric Oncology Consensus Statement. JAMA Oncol. Published online January 28, 2021. doi:10.1001/jamaoncol.2020.7582

Fontanella CA et al. Association of cannabis use with self-harm and mortality risk among youths with mood disorders. JAMA Pediatr. Published online January 19, 2021. doi:10.1001/jamapediatrics.2020.5494

Goldenberg JZ et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021;372:m4743

Huang J, Yang F, Chien W, et al. Risk of substance use disorder and its associations with comorbidities and psychotropic agents in patients with autism. JAMA Pediatr. Published online January 04, 2021.

Ezekowitz JA et al. Is there a sex gap in surviving an acute coronary syndrome or subsequent development of heart failure? Circulation, 30 november 2020.

Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet 2019;394(10204):1159-68.

Vinogradova Y et al. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ 2020; 371 :m3873

Una finestra sull’open access

  • BMC Family Practice
  • BMC Medical Education
  • BMC Nursing
  • BMJ Open
  • PLOS Medicine

Reset della password

Per favore inserisci la tua email. Riceverai una nuova password via email.